Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy

Ann Neurol. 2019 Aug;86(2):322-324. doi: 10.1002/ana.25523. Epub 2019 Jun 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Immunologic Factors
  • Intermediate Filaments
  • Leukoencephalopathy, Progressive Multifocal*
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting*
  • Natalizumab

Substances

  • Biomarkers
  • Immunologic Factors
  • Natalizumab